Switch to
More onapp

Torrent Pharmaceuticals Ltd

TORNTPHARM
Health CarePharmaceuticals
LargecapWith a market cap of ₹55,132 cr, stock is ranked 95
Low RiskStock is 1.60x as volatile as Nifty
1,625.004.00 (-0.25%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹55,132 cr, stock is ranked 95
Low RiskStock is 1.60x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
70.94
PB RatioPB Ratio
9.26
Dividend YieldDiv. Yield
1.47%
Sector PESector PE
35.64
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.89%

Forecast & RatingsDetailed Forecast 

68%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.

Brands

Torrent Pharma

Pharmaceutical company

Investor PresentationView older 

Oct 21, 2022

PDF
View Older Presentations

Brands

Torrent Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20192020202120227.738.068.068.700.441.021.250.78
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.06%

See detailed holdings

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 14, 2022

Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

Debentures 
Announced OnNov 9, 2022

Torrent Pharmaceuticals Limited has informed the Exchange about Intimation regarding issue of Non-Convertible Debentures on Private Placement basis | Download

Torrent Pharmaceuticals Limited has informed the Exchange about Intimation regarding issue of Non-Convertible Debentures on Private Placement basis | Download

Cash Dividend 
Ex. DateJun 3, 2022

Special • Div/Share: ₹ 15

See all events